Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Mathematical Modeling of Oncolytic Virotherapy.

Heidbuechel JPW, Abate-Daga D, Engeland CE, Enderling H.

Methods Mol Biol. 2020;2058:307-320. doi: 10.1007/978-1-4939-9794-7_21.

PMID:
31486048
2.

Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy.

Enderling H, Alfonso JCL, Moros E, Caudell JJ, Harrison LB.

Trends Cancer. 2019 Aug;5(8):467-474. doi: 10.1016/j.trecan.2019.06.006. Epub 2019 Jul 10. Review.

PMID:
31421904
3.

Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to.

Brady R, Enderling H.

Bull Math Biol. 2019 Jul 23. doi: 10.1007/s11538-019-00640-x. [Epub ahead of print]

PMID:
31338741
4.

Re: Simulation analysis for tumor radiotherapy based on three-component mathematical models.

Ferrall-Fairbanks MC, Glazar DJ, Brady RJ, Kimmel GJ, Zahid MU, Altrock PM, Enderling H.

J Appl Clin Med Phys. 2019 Jul;20(7):204-205. doi: 10.1002/acm2.12608. Epub 2019 May 30. No abstract available.

5.

Illuminating the Numbers: Integrating Mathematical Models to Optimize Photomedicine Dosimetry and Combination Therapies.

Spring BQ, Lang RT, Kercher EM, Rizvi I, Wenham RM, Conejo-Garcia JR, Hasan T, Gatenby RA, Enderling H.

Front Phys. 2019 Apr;7. pii: 46. doi: 10.3389/fphy.2019.00046. Epub 2019 Apr 2.

6.

The 2019 mathematical oncology roadmap.

Rockne RC, Hawkins-Daarud A, Swanson KR, Sluka JP, Glazier JA, Macklin P, Hormuth DA, Jarrett AM, Lima EABF, Tinsley Oden J, Biros G, Yankeelov TE, Curtius K, Al Bakir I, Wodarz D, Komarova N, Aparicio L, Bordyuh M, Rabadan R, Finley SD, Enderling H, Caudell J, Moros EG, Anderson ARA, Gatenby RA, Kaznatcheev A, Jeavons P, Krishnan N, Pelesko J, Wadhwa RR, Yoon N, Nichol D, Marusyk A, Hinczewski M, Scott JG.

Phys Biol. 2019 Jun 19;16(4):041005. doi: 10.1088/1478-3975/ab1a09.

7.

Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery.

López Alfonso JC, Poleszczuk J, Walker R, Kim S, Pilon-Thomas S, Conejo-Garcia JJ, Soliman H, Czerniecki B, Harrison LB, Enderling H.

JCO Clin Cancer Inform. 2019 Apr;3:1-16. doi: 10.1200/CCI.18.00075.

8.

Proliferation saturation index in an adaptive Bayesian approach to predict patient-specific radiotherapy responses.

Sunassee ED, Tan D, Ji N, Brady R, Moros EG, Caudell JJ, Yartsev S, Enderling H.

Int J Radiat Biol. 2019 Mar 4:1-6. doi: 10.1080/09553002.2019.1589013. [Epub ahead of print]

PMID:
30831050
9.

The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity.

Poleszczuk J, Enderling H.

Int J Mol Sci. 2018 Oct 29;19(11). pii: E3377. doi: 10.3390/ijms19113377.

10.

CD133 Expression as a Helicobacter pylori-independent Biomarker of Gastric Cancer Progression.

Howard R, Al Diffalha S, Pimiento J, Mejia J, Enderling H, Giuliano A, Coppola D.

Anticancer Res. 2018 Aug;38(8):4443-4448. doi: 10.21873/anticanres.12746.

PMID:
30061208
11.

Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy.

Walker R, Poleszczuk J, Pilon-Thomas S, Kim S, Anderson AARA, Czerniecki BJ, Harrison LB, Moros EG, Enderling H.

Sci Rep. 2018 Jun 21;8(1):9474. doi: 10.1038/s41598-018-27718-1.

12.

Temporally feathered intensity-modulated radiation therapy: A planning technique to reduce normal tissue toxicity.

López Alfonso JC, Parsai S, Joshi N, Godley A, Shah C, Koyfman SA, Caudell JJ, Fuller CD, Enderling H, Scott JG.

Med Phys. 2018 Jul;45(7):3466-3474. doi: 10.1002/mp.12988. Epub 2018 Jun 8.

13.

Evaluating the potential for maximized T cell redistribution entropy to improve abscopal responses to radiotherapy.

Walker R, Schoenfeld JD, Pilon-Thomas S, Poleszczuk J, Enderling H.

Converg Sci Phys Oncol. 2017 Sep;3(3). pii: 034001. doi: 10.1088/2057-1739/aa7269. Epub 2017 Jun 15.

14.

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017.

Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR Jr, Kachnic LA.

Clin Cancer Res. 2018 Aug 1;24(15):3500-3509. doi: 10.1158/1078-0432.CCR-17-3202. Epub 2018 Apr 16.

15.

The Evolution of Tumour Composition During Fractionated Radiotherapy: Implications for Outcome.

Lewin TD, Maini PK, Moros EG, Enderling H, Byrne HM.

Bull Math Biol. 2018 May;80(5):1207-1235. doi: 10.1007/s11538-018-0391-9. Epub 2018 Feb 27.

PMID:
29488054
16.

Mathematical Modeling of the Effects of Tumor Heterogeneity on the Efficiency of Radiation Treatment Schedule.

Forouzannia F, Enderling H, Kohandel M.

Bull Math Biol. 2018 Feb;80(2):283-293. doi: 10.1007/s11538-017-0371-5. Epub 2017 Dec 7.

PMID:
29218592
17.

Personalizing Gastric Cancer Screening With Predictive Modeling of Disease Progression Biomarkers.

Walker R, Mejia J, Lee JK, Pimiento JM, Malafa M, Giuliano AR, Coppola D, Enderling H.

Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):270-277. doi: 10.1097/PAI.0000000000000598.

PMID:
29084052
18.

Fighting Cancer with Mathematics and Viruses.

Santiago DN, Heidbuechel JPW, Kandell WM, Walker R, Djeu J, Engeland CE, Abate-Daga D, Enderling H.

Viruses. 2017 Aug 23;9(9). pii: E239. doi: 10.3390/v9090239. Review.

19.

Toward early detection of Helicobacter pylori-associated gastric cancer.

Walker R, Poleszczuk J, Mejia J, Lee JK, Pimiento JM, Malafa M, Giuliano AR, Enderling H, Coppola D.

Gastric Cancer. 2018 Mar;21(2):196-203. doi: 10.1007/s10120-017-0748-z. Epub 2017 Jul 19.

PMID:
28725964
20.

Predicting Patient-Specific Radiotherapy Protocols Based on Mathematical Model Choice for Proliferation Saturation Index.

Poleszczuk J, Walker R, Moros EG, Latifi K, Caudell JJ, Enderling H.

Bull Math Biol. 2018 May;80(5):1195-1206. doi: 10.1007/s11538-017-0279-0. Epub 2017 Jul 5.

PMID:
28681150
21.

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival.

Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, Soliman H, Enderling H.

Breast Cancer Res. 2017 Jun 30;19(1):75. doi: 10.1186/s13058-017-0870-1.

22.

Different Sequences of Fractionated Low-Dose Proton and Single Iron-Radiation-Induced Divergent Biological Responses in the Heart.

Sasi SP, Yan X, Zuriaga-Herrero M, Gee H, Lee J, Mehrzad R, Song J, Onufrak J, Morgan J, Enderling H, Walsh K, Kishore R, Goukassian DA.

Radiat Res. 2017 Aug;188(2):191-203. doi: 10.1667/RR14667.1. Epub 2017 Jun 14.

23.

Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx.

Shiao JC, Mohamed ASR, Messer JA, Hutcheson KA, Johnson JM, Enderling H, Kamal M, Warren BW, Pham B, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Kies MS, Ferrarotto R, Garden AS, Schomer DF, Gunn GB, Phan J, Frank SJ, Beadle BM, Weber RS, Lewin JS, Rosenthal DI, Fuller CD.

Head Neck. 2017 Aug;39(8):1609-1620. doi: 10.1002/hed.24804. Epub 2017 May 2.

24.

The future of personalised radiotherapy for head and neck cancer.

Caudell JJ, Torres-Roca JF, Gillies RJ, Enderling H, Kim S, Rishi A, Moros EG, Harrison LB.

Lancet Oncol. 2017 May;18(5):e266-e273. doi: 10.1016/S1470-2045(17)30252-8. Epub 2017 Apr 26. Review.

PMID:
28456586
25.

CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy.

Perni S, Mohamed AS, Scott J, Enderling H, Garden AS, Gunn GB, Rosenthal DI, Fuller CD.

Oral Oncol. 2016 Dec;63:16-22. doi: 10.1016/j.oraloncology.2016.10.022. Epub 2016 Nov 4.

26.

Stratifying prostate cancer patients by relative lymph node involvement: population- and modeling-based study.

Poleszczuk JT, Johnstone PA, Enderling H.

Cancer Med. 2016 Aug;5(8):1850-5. doi: 10.1002/cam4.776. Epub 2016 May 26.

27.

Agent-Based Modeling of Cancer Stem Cell Driven Solid Tumor Growth.

Poleszczuk J, Macklin P, Enderling H.

Methods Mol Biol. 2016;1516:335-346. doi: 10.1007/7651_2016_346.

28.

Corrigendum to "Particle Radiation-Induced Nontargeted Effects in Bone-Marrow-Derived Endothelial Progenitor Cells".

Sasi SP, Park D, Muralidharan S, Wage J, Kiladjian A, Onufrak J, Enderling H, Yan X, Goukassian DA.

Stem Cells Int. 2016;2016:7958361. doi: 10.1155/2016/7958361. Epub 2016 Jan 6.

29.

Cancer Stem Cell Plasticity as Tumor Growth Promoter and Catalyst of Population Collapse.

Poleszczuk J, Enderling H.

Stem Cells Int. 2016;2016:3923527. doi: 10.1155/2016/3923527. Epub 2015 Dec 8.

30.

Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions.

Poleszczuk JT, Luddy KA, Prokopiou S, Robertson-Tessi M, Moros EG, Fishman M, Djeu JY, Finkelstein SE, Enderling H.

Cancer Res. 2016 Mar 1;76(5):1009-18. doi: 10.1158/0008-5472.CAN-15-1423. Epub 2016 Feb 1.

31.

From concept to clinic: Mathematically informed immunotherapy.

Walker R, Enderling H.

Curr Probl Cancer. 2016 Jan-Feb;40(1):68-83. doi: 10.1016/j.currproblcancer.2015.10.004. Epub 2015 Oct 8. Review.

PMID:
26645497
32.

Correction: Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants.

Sasi SP, Bae S, Song J, Perepletchikov A, Schneider D, Carrozza J, Yan X, Kishore R, Enderling H, Goukassian DA.

PLoS One. 2015 Nov 30;10(11):e0144213. doi: 10.1371/journal.pone.0144213. eCollection 2015. No abstract available.

33.

TNF-TNFR2/p75 signaling inhibits early and increases delayed nontargeted effects in bone marrow-derived endothelial progenitor cells.

Sasi SP, Song J, Park D, Enderling H, McDonald JT, Gee H, Garrity B, Shtifman A, Yan X, Walsh K, Natarajan M, Kishore R, Goukassian DA.

J Biol Chem. 2015 Nov 6;290(45):27014. doi: 10.1074/jbc.A114.567743. No abstract available.

34.

Correction: Cardiovascular Risks Associated with Low Dose Ionizing Particle Radiation.

Yan X, Sasi SP, Gee H, Lee J, Yang Y, Mehrzad R, Onufrak J, Song J, Enderling H, Agarwal A, Rahimi L, Morgan J, Wilson PF, Carrozza J, Walsh K, Kishore R, Goukassian DA.

PLoS One. 2015 Nov 6;10(11):e0142764. doi: 10.1371/journal.pone.0142764. eCollection 2015. No abstract available.

35.

A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation.

Prokopiou S, Moros EG, Poleszczuk J, Caudell J, Torres-Roca JF, Latifi K, Lee JK, Myerson R, Harrison LB, Enderling H.

Radiat Oncol. 2015 Jul 31;10:159. doi: 10.1186/s13014-015-0465-x.

36.

Mathematical Modeling of Acupuncture as Cancer Symptom Therapy: First Steps.

Johnstone PA, Enderling H.

J Acupunct Meridian Stud. 2015 Jun;8(3):113-4. doi: 10.1016/j.jams.2015.03.001. Epub 2015 Mar 10. No abstract available.

37.

Particle Radiation-Induced Nontargeted Effects in Bone-Marrow-Derived Endothelial Progenitor Cells.

Sasi SP, Park D, Muralidharan S, Wage J, Kiladjian A, Onufrak J, Enderling H, Yan X, Goukassian DA.

Stem Cells Int. 2015;2015:496512. doi: 10.1155/2015/496512. Epub 2015 May 5. Erratum in: Stem Cells Int. 2016;2016:7958361.

38.

Therapeutic implications from sensitivity analysis of tumor angiogenesis models.

Poleszczuk J, Hahnfeldt P, Enderling H.

PLoS One. 2015 Mar 18;10(3):e0120007. doi: 10.1371/journal.pone.0120007. eCollection 2015.

39.

Evolution and phenotypic selection of cancer stem cells.

Poleszczuk J, Hahnfeldt P, Enderling H.

PLoS Comput Biol. 2015 Mar 5;11(3):e1004025. doi: 10.1371/journal.pcbi.1004025. eCollection 2015 Mar.

40.

Cancer stem cells: small subpopulation or evolving fraction?

Enderling H.

Integr Biol (Camb). 2015 Jan;7(1):14-23. doi: 10.1039/c4ib00191e. Review.

PMID:
25359461
41.

A High-Performance Cellular Automaton Model of Tumor Growth with Dynamically Growing Domains.

Poleszczuk J, Enderling H.

Appl Math (Irvine). 2014 Jan;5(1):144-152.

42.

Cardiovascular risks associated with low dose ionizing particle radiation.

Yan X, Sasi SP, Gee H, Lee J, Yang Y, Mehrzad R, Onufrak J, Song J, Enderling H, Agarwal A, Rahimi L, Morgan J, Wilson PF, Carrozza J, Walsh K, Kishore R, Goukassian DA.

PLoS One. 2014 Oct 22;9(10):e110269. doi: 10.1371/journal.pone.0110269. eCollection 2014. Erratum in: PLoS One. 2015;10(11):e0142764.

43.

A multicompartment mathematical model of cancer stem cell-driven tumor growth dynamics.

Weekes SL, Barker B, Bober S, Cisneros K, Cline J, Thompson A, Hlatky L, Hahnfeldt P, Enderling H.

Bull Math Biol. 2014 Jul;76(7):1762-82. doi: 10.1007/s11538-014-9976-0. Epub 2014 May 20.

44.

TNF-TNFR2/p75 signaling inhibits early and increases delayed nontargeted effects in bone marrow-derived endothelial progenitor cells.

Sasi SP, Song J, Park D, Enderling H, McDonald JT, Gee H, Garrity B, Shtifman A, Yan X, Walsh K, Natarajan M, Kishore R, Goukassian DA.

J Biol Chem. 2014 May 16;289(20):14178-93. doi: 10.1074/jbc.M114.567743. Epub 2014 Apr 7. Erratum in: J Biol Chem. 2015 Nov 6;290(45):27014.

45.

Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated replicative senescence.

Poleszczuk J, Hahnfeldt P, Enderling H.

Cell Prolif. 2014 Jun;47(3):267-76. doi: 10.1111/cpr.12101. Epub 2014 Mar 25.

PMID:
24666838
46.

Therapeutic non-toxic doses of TNF induce significant regression in TNFR2-p75 knockdown Lewis lung carcinoma tumor implants.

Sasi SP, Bae S, Song J, Perepletchikov A, Schneider D, Carrozza J, Yan X, Kishore R, Enderling H, Goukassian DA.

PLoS One. 2014 Mar 24;9(3):e92373. doi: 10.1371/journal.pone.0092373. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e101647. PLoS One. 2015;10(11):e0144213.

47.

Unveiling stem cell kinetics: prime time for integrating experimental and computational models.

Enderling H.

Front Oncol. 2013 Nov 28;3:291. doi: 10.3389/fonc.2013.00291. eCollection 2013. No abstract available.

48.

Mathematical modeling of tumor growth and treatment.

Enderling H, Chaplain MA.

Curr Pharm Des. 2014;20(30):4934-40. Review.

PMID:
24283955
49.

Simulating cancer: computational models in oncology.

Enderling H, Rejniak KA.

Front Oncol. 2013 Sep 13;3:233. doi: 10.3389/fonc.2013.00233. eCollection 2013. No abstract available.

50.

Formalizing an integrative, multidisciplinary cancer therapy discovery workflow.

McGuire MF, Enderling H, Wallace DI, Batra J, Jordan M, Kumar S, Panetta JC, Pasquier E.

Cancer Res. 2013 Oct 15;73(20):6111-7. doi: 10.1158/0008-5472.CAN-13-0310. Epub 2013 Aug 16.

Supplemental Content

Loading ...
Support Center